Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report

RATIONALE: Antiphospholipid syndrome (APS) in pregnancy may trigger the life-threatening catastrophic antiphospholipid syndrome (CAPS). Complement activation is implicated in the pathogenesis, and inhibition of complement factor C5 is suggested as an additional treatment option. PATIENT CONCERNS, DI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustavsen, Alice, Skattum, Lillemor, Bergseth, Grethe, Lorentzen, Bjorg, Floisand, Yngvar, Bosnes, Vidar, Mollnes, Tom Eirik, Barratt-Due, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369917/
https://www.ncbi.nlm.nih.gov/pubmed/28296762
http://dx.doi.org/10.1097/MD.0000000000006338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369917/
https://www.ncbi.nlm.nih.gov/pubmed/28296762
http://dx.doi.org/10.1097/MD.0000000000006338

Ejemplares similares